Cenedella.de

Patient Advocate since 1977.


2 Comments

Germany: Cultivation License, tender information

Germany-Bonn: medical equipment, pharmaceuticals and personal care products

http://ted.europa.eu/udl?uri=TED:NOTICE:131987-2017:TEXT:DE:HTML&src=0#id1042115-III.

2017 / S 070-131987

contract notice

Supplies

Directive 2014/24 / EU

Section I: Contracting authorities

I.1)Name and addresses

Federal Institute for Drugs and Medical Devices (BfArM)
Kurt-Georg-Kiesinger-Allee 3
Bonn
53175
Germany
Contact: Bundesinstitut für Arzneimittel und Medizinprodukte, Frau Stefanie Vogt
Phone: +49 228-2074124
E-Mail: Z122@bfarm.de
Fax : +49 228-2074352
NUTS Code: DEA22Internet address (es):Main address: http://www.bfarm.de

I.2)Common procurement strategy

I.3) Address from whichfurther information can be obtained:

The order documents are available free of charge for full and complete direct access at: https://www.evergabe-online.de/tenderdetails.html?id=156533
Further information can be obtained from the above-mentioned contact point (s)
Tenders or requests to participate must be submitted to the above mentioned contact point (s)

I.4)Type of the contracting authority

Ministry or other central or federal authority, including regional or local subdivisions

I.5)Main activity (s)

health

Section II: Subject

II.1)Scope of procurement

II.1.1) Titleattributed to the contract:

Cultivation, processing, storage, packaging and delivery of cannabis for medical purposes.

Reference number of the contract notice: 2281-1713

II.1.2) Mainterms of the sale or purchase:

33000000

II.1.3)Type of contract

Supplies

II.1.4)Short description:

Cultivation, further processing, storage, packaging and delivery of cannabis for medical purposes in a secure inhouse plantation in Germany.

II.1.5)Estimated total value

II.1.6)Information about lots

Division of the contract into lots: yes
Offers are possible for all lots
Maximum number of lots to be awarded to a contracting authority: 7
II.2)Description

II.2.1)Title attributed to the contract:

Cultivation, processing, storage, packaging and delivery of cannabis for medical purposes in a secure inhouse plantation in Germany

Lot No: 1

II.2.2)Additional CPV code (s)

03117120

II.2.3)Place of performance

NUTS code: DEA22

II.2.4)Description of the sourcing:

Cultivation, processing, storage, packaging and delivery of cannabis (type 1): delivery period 2019 to 2022, delivery volume approx. 200 kg per year.

II.2.5)Award criteria

The price is not the only supplementary criterion; All criteria are listed in the procurement documents only
II.2.6)Estimated value

II.2.7)Duration of the contract or framework agreement or of the dynamic purchasing system

Duration in months:
This contract can be extended: no

II.2.9)Indication about the number of operators who will be invited to tender or to participate

Planned number of candidates: 10
Objective criteria for selecting the limited number of applicants:

(A) references to earlier contracts awarded by the applicant for the cultivation, processing and delivery of cannabis for medical purposes with a delivery quantity of at least 50 kg per reference for the last 3 years. A reference to an order for the cultivation, processing and delivery of medical cannabis shall also apply if, with the consent of the competent authority in the country concerned, the tenderer submits directly to this body in accordance with Article 23 of the 1961 Unified Agreement on Narcotic Drugs A variety of different performance receivers have been delivered and the total delivery quantity has amounted to at least 50 kg. The applicant will receive 10 points (maximum 40 points) per 50 kg of delivery (whether in the context of one or more orders).

(B) references to the cultivation, processing and supply of medicinal plants (without cannabis) with a delivery quantity of at least 50 kg per reference over the last three years (whether in the case of a single order or several contracts) Points (maximum score 20 points).

C) If more than 10 applicants receive a score of more than 60, the selection is based on the highest total delivery quantity in the last three years according to lit. A), according to lit. b).

D) If fewer than 10 applicants receive a score of 60, the selection is based on the highest total delivery quantity in the last three years according to lit. A), according to lit. b).

II.2.10)Information about variants / alternative offers

Variants / alternative offers are permitted: no

II.2.11) Informationon options

Options: no
II.2.12)Information about electronic catalogs

II.2.1)Information about European Union funds

The contract is linked to a project and / or program financed by the EU: no
II.2.1)Additional information
II.2)Description

II.2.1)Title attributed to the contract:

Cultivation, further processing, storage, packaging and delivery of cannabis for medical purposes in a secure inhouse plantation in Germany.

Lot No: 2

II.2.2)Additional CPV code (s)

03117120

II.2.3)Place of performance

NUTS code: DEA22

II.2.4)Description of the sourcing:

Cultivation, processing, storage, packaging and delivery of cannabis (type 1): delivery period 2019 to 2022, delivery volume approx. 200 kg per year.

II.2.5)Award criteria

The price is not the only supplementary criterion; All criteria are listed in the procurement documents only
II.2.6)Estimated value

II.2.7)Duration of the contract or framework agreement or of the dynamic purchasing system

Duration in months:
This contract can be extended: no

II.2.9)Indication about the number of operators who will be invited to tender or to participate

Planned number of candidates: 10
Objective criteria for selecting the limited number of applicants:

(A) references to earlier contracts awarded by the applicant for the cultivation, processing and delivery of cannabis for medical purposes with a delivery quantity of at least 50 kg per reference for the last 3 years. A reference to an order for the cultivation, processing and delivery of medical cannabis shall also apply if, with the consent of the competent authority in the country concerned, the tenderer submits directly to this body in accordance with Article 23 of the 1961 Unified Agreement on Narcotic Drugs A variety of different performance receivers have been delivered and the total delivery quantity has amounted to at least 50 kg. The applicant will receive 10 points (maximum 40 points) per 50 kg of delivery (whether in the context of one or more orders).

(B) references to the cultivation, processing and supply of medicinal plants (without cannabis) with a minimum quantity of 50 kg per reference for the last three years (whether in the case of a single order or several contracts): the applicant receives 5 points per 50 kg delivery (A maximum of 20 points).

C) If more than 10 applicants receive a score of more than 60, the selection is based on the highest total quantity delivered in the last three years according to lit. A), according to lit. b).

II.2.10)Information about variants / alternative offers

Variants / alternative offers are permitted: no

II.2.11) Informationon options

Options: no
II.2.12)Information about electronic catalogs

II.2.1)Information about European Union funds

The contract is linked to a project and / or program financed by the EU: no
II.2.1)Additional information
II.2)Description

II.2.1)Title attributed to the contract:

Cultivation, further processing, storage, packaging and delivery of cannabis for medical purposes in a secure inhouse plantation in Germany.

Lot No: 3

II.2.2)Additional CPV code (s)

03117120

II.2.3)Place of performance

NUTS code: DEA22

II.2.4)Description of the sourcing:

Cultivation, processing, storage, packaging and delivery of cannabis (type 1): delivery period 2019 to 2022, delivery volume approx. 200 kg per year.

II.2.5)Award criteria

The price is not the only supplementary criterion; All criteria are listed in the procurement documents only
II.2.6)Estimated value

II.2.7)Duration of the contract or framework agreement or of the dynamic purchasing system

Duration in months:
This contract can be extended: no

II.2.9)Indication about the number of operators who will be invited to tender or to participate

Planned number of candidates: 10
Objective criteria for selecting the limited number of applicants:

(A) references to earlier contracts awarded by the applicant for the cultivation, processing and delivery of cannabis for medical purposes with a delivery quantity of at least 50 kg per reference for the last 3 years. A reference to an order for the cultivation, processing and delivery of medical cannabis shall also apply if, with the consent of the competent authority in the country concerned, the tenderer submits directly to this body in accordance with Article 23 of the 1961 Unified Agreement on Narcotic Drugs A variety of different performance receivers have been delivered and the total delivery quantity has amounted to at least 50 kg. The applicant will receive 10 points (maximum 40 points) per 50 kg of delivery (whether in the context of one or more orders).

(B) references to the cultivation, processing and supply of medicinal plants (without cannabis) with a minimum quantity of 50 kg per reference over the last three years (whether in the context of one or more contracts): The applicant shall be supplied per 50 kg of delivery 5 points (maximum score 20 points).

C) If more than 10 applicants receive a score of more than 60, the selection is based on the highest total delivery quantity in the last three years according to lit. A), according to lit. b).

D) If fewer than 10 applicants receive a score of 60, the selection is based on the highest total delivery quantity in the last three years according to lit. A), according to lit. b).

II.2.10)Information about variants / alternative offers

Variants / alternative offers are permitted: no

II.2.11) Informationon options

Options: no
II.2.12)Information about electronic catalogs

II.2.1)Information about European Union funds

The contract is linked to a project and / or program financed by the EU: no
II.2.1)Additional information
II.2)Description

II.2.1)Title attributed to the contract:

Cultivation, further processing, storage, packaging and delivery of cannabis for medical purposes in a secure inhouse plantation in Germany.

Lot No: 4

II.2.2)Additional CPV code (s)

03117120

II.2.3)Place of performance

NUTS code: DEA22

II.2.4)Description of the sourcing:

Cultivation, processing, storage, packaging and delivery of cannabis (type 1): delivery period 2020 to 2022, delivery volume approx. 200 kg per year.

II.2.5)Award criteria

The price is not the only supplementary criterion; All criteria are listed in the procurement documents only
II.2.6)Estimated value

II.2.7)Duration of the contract or framework agreement or of the dynamic purchasing system

Duration in months:
This contract can be extended: no

II.2.9)Indication about the number of operators who will be invited to tender or to participate

Planned number of candidates: 10
Objective criteria for selecting the limited number of applicants:

(A) references to earlier contracts awarded by the applicant for the cultivation, processing and delivery of cannabis for medical purposes with a delivery quantity of at least 50 kg per reference for the last 3 years. A reference to an order for the cultivation, processing and delivery of medical cannabis shall also apply if, with the consent of the competent authority in the country concerned, the tenderer submits directly to this body in accordance with Article 23 of the 1961 Unified Agreement on Narcotic Drugs A variety of different performance receivers have been delivered and the total delivery quantity has amounted to at least 50 kg. The applicant will receive 10 points (maximum of 40 points) for each 50 kg of delivery (whether for one or more orders).

(B) references to the cultivation, processing and supply of medicinal plants (without cannabis) with a delivery quantity of at least 50 kg per reference over the last three years (whether in the case of a single order or several contracts) Points (maximum score 20 points).

C) If more than 10 applicants receive a score of more than 60, the selection is based on the highest total delivery quantity in the last three years according to lit. A), according to lit. b).

D) If fewer than 10 applicants receive a score of 60, the selection is based on the highest total delivery quantity in the last three years according to lit. A), according to lit. b).

II.2.10)Information about variants / alternative offers

Variants / alternative offers are permitted: no

II.2.11) Informationon options

Options: no
II.2.12)Information about electronic catalogs

II.2.1)Information about European Union funds

The contract is linked to a project and / or program financed by the EU: no
II.2.1)Additional information
II.2)Description

II.2.1)Title attributed to the contract:

Cultivation, further processing, storage, packaging and delivery of cannabis for medical purposes in a secure inhouse plantation in Germany.

Lot No: 5

II.2.2)Additional CPV code (s)

03117120

II.2.3)Place of performance

NUTS code: DEA22

II.2.4)Description of the sourcing:

Cultivation, processing, storage, packaging and delivery of cannabis (type 1): delivery period 2020 to 2022, delivery volume approx. 200 kg per year.

II.2.5)Award criteria

The price is not the only supplementary criterion; All criteria are listed in the procurement documents only
II.2.6)Estimated value

II.2.7)Duration of the contract or framework agreement or of the dynamic purchasing system

Duration in months:
This contract can be extended: no

II.2.9)Indication about the number of operators who will be invited to tender or to participate

Planned number of candidates: 10
Objective criteria for selecting the limited number of applicants:

(A) references to earlier contracts awarded by the applicant for the cultivation, processing and delivery of cannabis for medical purposes with a delivery quantity of at least 50 kg per reference for the last 3 years. A reference to an order for the cultivation, processing and delivery of medical cannabis shall also apply if, with the consent of the competent authority in the country concerned, the tenderer submits directly to this body in accordance with Article 23 of the 1961 Unified Agreement on Narcotic Drugs A variety of different performance receivers have been delivered and the total delivery quantity has amounted to at least 50 kg. The applicant will receive 10 points (maximum of 40 points) for each 50 kg of delivery (whether for one or more orders).

(B) references to the cultivation, processing and supply of medicinal plants (without cannabis) with a delivery quantity of at least 50 kg per reference over the last three years (whether in the case of a single order or several contracts) Points (maximum score 20 points).

C) If more than 10 applicants receive a score of more than 60, the selection is based on the highest total delivery quantity in the last three years according to lit. A), according to lit. b).

D) If fewer than 10 applicants receive a score of 60, the selection is based on the highest total delivery quantity in the last three years according to lit. A), according to lit. b).

II.2.10)Information about variants / alternative offers

Variants / alternative offers are permitted: no

II.2.11) Informationon options

Options: no
II.2.12)Information about electronic catalogs

II.2.1)Information about European Union funds

The contract is linked to a project and / or program financed by the EU: no
II.2.1)Additional information
II.2)Description

II.2.1)Title attributed to the contract:

Cultivation, further processing, storage, packaging and delivery of cannabis for medical purposes in a secure inhouse plantation in Germany.

Lot No: 6

II.2.2)Additional CPV code (s)

03117120

II.2.3)Place of performance

NUTS code: DEA22

II.2.4)Description of the sourcing:

Cultivation, processing, storage, packaging and delivery of cannabis (type 1): delivery period 2021 to 2022, delivery quantity approx. 200 kg per year.

II.2.5)Award criteria

The price is not the only supplementary criterion; All criteria are listed in the procurement documents only
II.2.6)Estimated value

II.2.7)Duration of the contract or framework agreement or of the dynamic purchasing system

Duration in months:
This contract can be extended: no

II.2.9)Indication about the number of operators who will be invited to tender or to participate

Planned number of candidates: 10
Objective criteria for selecting the limited number of applicants:

(A) references to earlier contracts awarded by the applicant for the cultivation, processing and delivery of cannabis for medical purposes with a delivery quantity of at least 50 kg per reference for the last 3 years. A reference to an order for the cultivation, processing and delivery of medical cannabis shall also apply if, with the consent of the competent authority in the country concerned, the tenderer submits directly to this body in accordance with Article 23 of the 1961 Unified Agreement on Narcotic Drugs A variety of different performance receivers have been delivered and the total delivery quantity has amounted to at least 50 kg. The applicant will receive 10 points (maximum 40 points) per 50 kg of delivery (whether in the context of one or more orders).

(B) references to the cultivation, processing and supply of medicinal plants (without cannabis) with a delivery quantity of at least 50 kg per reference over the last three years (whether in the case of a single order or several contracts) Points (maximum score 20 points).

C) If more than 10 applicants receive a score of more than 60, the selection is based on the highest total delivery quantity in the last three years according to lit. A), according to lit. b).

D) If fewer than 10 applicants receive a score of 60, the selection is based on the highest total delivery quantity in the last three years according to lit. A), according to lit. b).

II.2.10)Information about variants / alternative offers

Variants / alternative offers are permitted: no

II.2.11) Informationon options

Options: no
II.2.12)Information about electronic catalogs

II.2.1)Information about European Union funds

The contract is linked to a project and / or program financed by the EU: no
II.2.1)Additional information
II.2)Description

II.2.1)Title attributed to the contract:

Cultivation, further processing, storage, packaging and delivery of cannabis for medical purposes in a secure inhouse plantation in Germany.

Lot No: 7

II.2.2)Additional CPV code (s)

03117120

II.2.3)Place of performance

NUTS code: DEA22

II.2.4)Description of the sourcing:

Cultivation, processing, storage, packaging and delivery of cannabis (type 2): delivery period 2019 to 2022, delivery volume approx. 200 kg per year.

II.2.5)Award criteria

The price is not the only supplementary criterion; All criteria are listed in the procurement documents only
II.2.6)Estimated value

II.2.7)Duration of the contract or framework agreement or of the dynamic purchasing system

Duration in months:
This contract can be extended: no

II.2.9)Indication about the number of operators who will be invited to tender or to participate

Planned number of candidates: 10
Objective criteria for selecting the limited number of applicants:

(A) references to earlier contracts awarded by the applicant for the cultivation, processing and delivery of cannabis for medical purposes with a delivery quantity of at least 50 kg per reference for the last 3 years. A reference to an order for the cultivation, processing and delivery of medical cannabis shall also apply if, with the consent of the competent authority in the country concerned, the tenderer submits directly to this body in accordance with Article 23 of the 1961 Unified Agreement on Narcotic Drugs A variety of different performance receivers have been delivered and the total delivery quantity has amounted to at least 50 kg. The applicant will receive 10 points (maximum of 40 points) for each 50 kg of delivery (whether for one or more orders).

(B) references to the cultivation, processing and supply of medicinal plants (without cannabis) with a delivery quantity of at least 50 kg per reference over the last three years (whether in the case of a single order or several contracts) Points (maximum score 20 points).

C) If more than 10 applicants receive a score of more than 60, the selection is based on the highest total delivery quantity in the last three years according to lit. A), according to lit. b).

D) If fewer than 10 applicants receive a score of 60, the selection is based on the highest total delivery quantity in the last three years according to lit. A), according to lit. b).

II.2.10)Information about variants / alternative offers

Variants / alternative offers are permitted: no

II.2.11) Informationon options

Options: no
II.2.12)Information about electronic catalogs

II.2.1)Information about European Union funds

The contract is linked to a project and / or program financed by the EU: no
II.2.1)Additional information
II.2)Description

II.2.1)Title attributed to the contract:

Cultivation, further processing, storage, packaging and delivery of cannabis for medical purposes in a secure inhouse plantation in Germany.

Lot No: 8

II.2.2)Additional CPV code (s)

03117120

II.2.3)Place of performance

NUTS code: DEA22

II.2.4)Description of the sourcing:

Cultivation, processing, storage, packaging and delivery of cannabis (type 2): delivery period 2020 to 2022, delivery volume approx. 200 kg per year.

II.2.5)Award criteria

The price is not the only supplementary criterion; All criteria are listed in the procurement documents only
II.2.6)Estimated value

II.2.7)Duration of the contract or framework agreement or of the dynamic purchasing system

Duration in months:
This contract can be extended: no

II.2.9)Indication about the number of operators who will be invited to tender or to participate

Planned number of candidates: 10
Objective criteria for selecting the limited number of applicants:

(A) references to earlier contracts awarded by the applicant for the cultivation, processing and delivery of cannabis for medical purposes with a delivery quantity of at least 50 kg per reference for the last 3 years. A reference to an order for the cultivation, processing and delivery of medical cannabis shall also apply if, with the consent of the competent authority in the country concerned, the tenderer submits directly to this body in accordance with Article 23 of the 1961 Unified Agreement on Narcotic Drugs A variety of different performance receivers have been delivered and the total delivery quantity has amounted to at least 50 kg. The applicant will receive 10 points (maximum of 40 points) for each 50 kg of delivery (whether for one or more orders).

(B) references to the cultivation, processing and supply of medicinal plants (without cannabis) with a delivery quantity of at least 50 kg per reference over the last three years (whether in the case of a single order or several contracts) Points (maximum score 20 points).

C) If more than 10 applicants receive a score of more than 60, the selection is based on the highest total delivery quantity in the last three years according to lit. A), according to lit. b).

D) If fewer than 10 applicants receive a score of 60, the selection is based on the highest total delivery quantity in the last three years according to lit. A), according to lit. b).

II.2.10)Information about variants / alternative offers

Variants / alternative offers are permitted: no

II.2.11) Informationon options

Options: no
II.2.12)Information about electronic catalogs

II.2.1)Information about European Union funds

The contract is linked to a project and / or program financed by the EU: no
II.2.1)Additional information
II.2)Description

II.2.1)Title attributed to the contract:

Cultivation, further processing, storage, packaging and delivery of cannabis for medical purposes in a secure inhouse plantation in Germany.

Lot No: 9

II.2.2)Additional CPV code (s)

03117120

II.2.3)Place of performance

NUTS code: DEA22

II.2.4)Description of the sourcing:

Cultivation, processing, storage, packaging and delivery of cannabis (type 3): delivery period 2019 to 2022, delivery volume approx. 200 kg per year.

II.2.5)Award criteria

The price is not the only supplementary criterion; All criteria are listed in the procurement documents only
II.2.6)Estimated value

II.2.7)Duration of the contract or framework agreement or of the dynamic purchasing system

Duration in months:
This contract can be extended: no

II.2.9)Indication about the number of operators who will be invited to tender or to participate

Planned number of candidates: 10
Objective criteria for selecting the limited number of applicants:

(A) references to earlier contracts awarded by the applicant for the cultivation, processing and delivery of cannabis for medical purposes with a delivery quantity of at least 50 kg per reference for the last 3 years. A reference to an order for the cultivation, processing and delivery of medical cannabis shall also apply if, with the consent of the competent authority in the country concerned, the tenderer submits directly to this body in accordance with Article 23 of the 1961 Unified Agreement on Narcotic Drugs A variety of different performance receivers have been delivered and the total delivery quantity has amounted to at least 50 kg. The applicant will receive 10 points (maximum 40 points) per 50 kg of delivery (whether in the context of one or more orders).

(B) references to the cultivation, processing and supply of medicinal plants (without cannabis) with a delivery quantity of at least 50 kg per reference over the last three years (whether in the case of a single order or several contracts) Points (maximum score 20 points).

C) If more than 10 applicants receive a score of more than 60, the selection is based on the highest total delivery quantity in the last three years according to lit. A), according to lit. b).

D) If fewer than 10 applicants receive a score of 60, the selection is based on the highest total delivery quantity in the last three years according to lit. A), according to lit. b).

II.2.10)Information about variants / alternative offers

Variants / alternative offers are permitted: no

II.2.11) Informationon options

Options: no
II.2.12)Information about electronic catalogs

II.2.1)Information about European Union funds

The contract is linked to a project and / or program financed by the EU: no
II.2.1)Additional information
II.2)Description

II.2.1)Title attributed to the contract:

Cultivation, further processing, storage, packaging and delivery of cannabis for medical purposes in a secure inhouse plantation in Germany.

Lot No: 10

II.2.2)Additional CPV code (s)

03117120

II.2.3)Place of performance

NUTS code: DEA22

II.2.4)Description of the sourcing:

Cultivation, processing, storage, packaging and delivery of cannabis (type 3): delivery period 2021 to 2022, delivery quantity approx. 200 kg per year.

II.2.5)Award criteria

The price is not the only supplementary criterion; All criteria are listed in the procurement documents only
II.2.6)Estimated value

II.2.7)Duration of the contract or framework agreement or of the dynamic purchasing system

Duration in months:
This contract can be extended: no

II.2.9)Indication about the number of operators who will be invited to tender or to participate

Planned number of candidates: 10
Objective criteria for selecting the limited number of applicants:

(A) references to earlier contracts awarded by the applicant for the cultivation, processing and delivery of cannabis for medical purposes with a delivery quantity of at least 50 kg per reference for the last 3 years. A reference to an order for the cultivation, processing and delivery of medical cannabis shall also apply if, with the consent of the competent authority in the country concerned, the tenderer submits directly to this body in accordance with Article 23 of the 1961 Unified Agreement on Narcotic Drugs A variety of different performance receivers have been delivered and the total delivery quantity has amounted to at least 50 kg. The applicant will receive 10 points (maximum 40 points) per 50 kg of delivery (whether in the context of one or more orders).

(B) references to the cultivation, processing and supply of medicinal plants (without cannabis) with a minimum quantity of 50 kg per reference over the last three years (whether in the context of one or more contracts): The applicant shall be supplied per 50 kg of delivery 5 points (maximum score 20 points).

C) If more than 10 applicants receive a score of more than 60, the selection is based on the highest total delivery quantity in the last three years according to lit. A), according to lit. b).

D) If fewer than 10 applicants receive a score of 60, the selection is based on the highest total delivery quantity in the last three years according to lit. A), according to lit. b).

II.2.10)Information about variants / alternative offers

Variants / alternative offers are permitted: no

II.2.11) Informationon options

Options: no
II.2.12)Information about electronic catalogs

II.2.1)Information about European Union funds

The contract is linked to a project and / or program financed by the EU: no
II.2.1)Additional information

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation

III.1.1)Empowerment in professional or professional capacity, including requirements relating to the professional or trade registers

Listing and brief description of the conditions:

The tenderer’s declaration of entry in a professional or trade register or other proof of the professional qualification required in the State in which the applicant is established.

The client reserves the right to submit the following documents within the framework of the appraisal of the participation requests to a separate request:

– Local business register,

– a certificate from the competent social security authorities that social security contributions are paid in accordance with the regulations,

– the certificate of the competent professional association that the tenderer is a member there and who is contributing,

– Tax exemption certificate issued by the tax office,

– Declaration on the grounds of exclusion pursuant to §§ 123, 124 GWB.

III.1.2)Economic and financial capacity

List and brief description of the suitability criteria:

– the total turnover of the applicant in the last three financial years, if any.

– information on the applicant’s turnover in the area of ​​the cultivation, processing and delivery of cannabis for medical purposes, where available.

– an indication of the applicant’s turnover in the area of ​​the cultivation, processing and supply of medicinal plants during the last three financial years, where available.

– an indication of the existence of a professional or occupational liability insurance amounting to EUR 5 million (twice a year maximized) or the tenderer’s assurance to conclude such insurance in the case of the subdivision.

– submit the candidates’ annual accounts, if their publication is legally required by the applicant.

– indication that the financing of the contract is to be secured (financing by equity, shareholder loans, loans from a credit institution or similar), as well as the insurer’s insurance A corresponding commitment from the financing credit institution.

III.1.3)Technical capacity and professional capacity

List and brief description of the suitability criteria:

Information on the tenderer ‘s previous contracts for the cultivation, processing and delivery of medical cannabis in the last three years, if any (list showing the contract value, the delivery quantity, the delivery period and the recipient of the service and, where available, Country competent authority in accordance with Article 23 of the “Unity Convention 1961 on Narcotics” concluded in New York on 30 March 1961).

– information on the tenderer’s references to contracts for the cultivation, processing and delivery of medicinal plants carried out in the past three years, where available (list showing the contract value, the delivery volume, the delivery period and the beneficiary).

– indication of the technical personnel to be used by the tenderer in connection with the service.

– information on the equipment, equipment and technical equipment of the contractors to carry out the contract.

Minimum standards required:

At least one reference for the purpose of cultivation, processing and delivery of medicinal cannabis (minimum quantity of 50 kg) or a contract for the cultivation, processing and supply of medicinal plants (minimum 50 kg) for the last three years. A reference to a contract for the planting and delivery of medical cannabis shall also apply if, with the consent of the competent authority in the country concerned, the tenderer submits directly to a variety of different beneficiaries, in accordance with Article 23 of the “Unified Convention on Narcotic Drugs” And the total quantity delivered is at least 50 kg. As a reference about an order to cultivate,

III.1.5)Information about reserved contracts
III.2)Conditions relating to the contract

III.2.2)Conditions relating to the performance of the contract:

Permission according to § 3 Drugs Act.

Permission according to § 13 Arzneimittelgesetz.

III.2.3)Personnel responsible for execution of the contract

Obligation to indicate the names and professional qualifications of the persons responsible for the execution of the contract

Section IV: Procedure

IV.1)Description

IV.1.1) Type ofprocedure

negotiated procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system (DPS)

IV.1.4) Informationabout reduction of the number of operators or solutions to be taken during the negotiation or dialogue

The succession of the procedure in successive stages in order to gradually reduce the number of solutions to be discussed and / or the tenders to be negotiated
IV.1.5)Information about a negotiated procedure
IV.1.6)Information about electronic auction

IV.1.8) Informationabout the Procurement Agreement (GPA)

The contract is covered by the Procurement Agreement: no
IV.2)Administrative informationIV.3)
IV.2.1)Previous publication concerning this procedure

IV.2.2)Time-limit for receipt of tenders or requests to participate

Day: 05/06/2017
Local Time: 12:00

IV.2.3)Time-limit for receipt of tenders or requests to participate:

Day: 28/06/2017

IV.2.4)Language (s) in which tenders or requests to participate may be drawn up:

German

IV.2.6)Minimum time frame during which the tenderer must maintain the tender

Duration in months: 6 (from the date of receipt of tenders)
IV.2.7)Conditions for opening tenders

Section VI: Additional information

VI.1)Information about a return of the contract

This is a recurring job: yes
Estimated timing for further notices:

02/01/2021.

VI.2)Information about electronic work processes

No. VI.3)Additional information:

Details of the invitation to tender and of the documents to be submitted can be found in the tender form “Procurement procedure for the cultivation, processing, storage, packaging and delivery of cannabis for medical purposes, here: Invitation to submit applications for participation”, which forms part of the tender documents.

This procurement procedure will be carried out electronically on the website of the eVergabe platform ( www.evergabe-online.de ).

Please note that the free download of the tender documents is only for a first view. In order to participate in the tender, you must apply for participation. Only if you apply for the tender, you will be actively informed about any changes to the tender documents and will be able to ask questions about the tender or receive the answers.

Any legal or professional questions concerning the award procedure or the tender documents must be addressed to the eVergabe platform.

VI.4)Procedures for appeal / review

VI.4.1) Bodyresponsible for appeal procedures

Awarding Office of the
Confederation Villemombler Straße 76
Bonn
53123
Germany
VI.4.2)Body responsible for appeal procedures

VI.4.3)Lodging of appeals

Precise information on the time limits for lodging appeals:

Section 160 GWB

(1) The awarding authority shall initiate a review procedure only upon request.

2. Any undertaking which is interested in the public contract or the concession and who asserts an infringement in its rights pursuant to Article 97 (6) by not observing public procurement rules shall have the right to submit applications. It must be shown that the alleged infringement of the public procurement rules has caused or is likely to result in damage to the company.

(3) The application is inadmissible in so far as:

1. the applicant has recognized the alleged infringement of public procurement rules before submitting the request for review and has not complained to the contracting authority within a period of ten calendar days; The expiry of the time limit pursuant to Section 134 (2) shall remain unaffected,

2. Infringements of public procurement rules which are discernible on the basis of the notice shall not be complained to the contracting authority not later than the expiry of the period set out in the notice of invitation to tender,

3. Infringements of the public procurement rules, which are only recognizable in the tender documents, are not complained against the contracting authority at the latest until the expiry of the deadline for the application or tender,

4. have passed more than 15 calendar days after receipt of the notice of the contracting authority not to remedy a complaint.

VI.4.4)Service from which information about the lodging of appeals may be obtained

Awarding Office of the
Confederation Villemombler Straße 76
Bonn
53123
Germany

VI.5)Date of dispatch of this notice:

04/04/2017


Leave a comment

Legal Approaches to Decriminalize Cannabis in 16 Different Countries

Legal Approaches to Decriminalize Cannabis in 16 Different Countries

This report, prepared by the foreign law specialists and analysts of the Law Library of Congress, provides a review of laws adopted in Argentina, Australia, Brazil, Canada, Costa Rica, the Czech Republic, Germany, Ireland, Israel, Mexico, the Netherlands, New Zealand, Norway, Portugal, South Africa, and Uruguay with regard to decriminalization of narcotics, and touches specifically on cannabis and legalization.

Individual country surveys included in the study demonstrate varied approaches to the problem of prosecuting drug use, possession, manufacturing, purchase, and sale. The country surveys demonstrate some diversity and common threads among these jurisdictions as to defining narcotics, distinguishing between “hard” and “soft” drugs, establishing special regulations concerning cannabis, refusing to prosecute personal use and/or possession of small quantities of drugs for personal use, giving law enforcement authorities the discretion not to prosecute minors and first-time offenders, applying alternative forms of punishment, and providing treatment opportunities.

Netherlands

Planning a trip to Amsterdam? Did you know that coffee shops are actually prohibited from selling drugs to you under Dutch law, and that nonresidents are not even supposed to enter the coffee shops? But wait, before you freak out and cancel your plans, know that Amsterdam tolerates the sale of certain “soft drugs” to foreigners looking to try what Amsterdam is best-known for. Local mayors have the authority to close such shops for not adhering to local rules, but they typically do not step in to assign punishments.

Dutch coffee shops rely on income from tourists, which in turn contributes to local economies, so officials do not typically enforce the residency requirement.

Germany

If you get caught by police in Germany, don’t even try to argue soft drug versus hard drug. Law enforcement doesn’t recognize the difference. The distinction between hard and soft drugs can only be considered at sentencing.

Australia

You should know that there is no national decriminalization policy, and cannabis use is technically considered illegal across the county. However, three jurisdictions (Australian Capital Territory, South Australia, and Northern Territory) have decriminalized minor cannabis offenses, especially possession of the plant.

Costa Rica

The use of narcotics in Costa Rica, including personal use, is prohibited by law; but no penalty for such violation is found on the books. Police, prosecutors, and the courts have discretion to drop charges if it is a minor, first-time offense, or the accused is willing to enter a treatment program.

Mexico

Although possession of illegal drugs is generally a crime under Mexican law, possession of less than 5 grams is not criminally punishable. However, if you are caught, a rule enacted in 2009 requires that you must be referred to an addiction treatment program.

“The ruling eliminates the prohibition and criminalization of acts related to the medicinal use of marijuana and its scientific research, and those relating to the production and distribution of the plant for these purposes,” the Lower House said in a statement on its website.

Mexico’s Lower House of Congress passed a bill on Friday, April 28, to legalize the use of cannabis for medical and scientific needs. The measure passed in a general floor vote 371-7-11, and now classifies delta-9-tetrahydrocannabinol (THC) as “therapeutic.”

The bill is now on President Enrique Pena Nieto’s desk, who is expected to sign it.

Uruguay

For now, it appears that the only country where it is completely legal to produce and use cannabis is Uruguay, although consuming cannabis in a public place is prohibited.

Adopted in 2013, Uruguay’s Law to Legalize and Regulate Cannabis brought radical change to the country’s approach to cannabis production and use. The law allows legal access to cannabis in four ways: medical marijuana through the Ministry of Health, home-grown marijuana, membership clubs, and sales to adults in drugstores. Although registration of consumers and cannabis clubs has been completed, implementation of sales in pharmacies is still underway.

Read the full report for free

These and many other interesting facts can be found in a recently published Law Library of Congress report on decriminalization of narcotics. Some diversity and common threads are demonstrated among the 16 countries included in the free report, such as defining narcotics, distinguishing between hard and soft drugs, establishing special regulations concerning cannabis, and discussion of the parameters of law enforcement and forms of punishment for personal use and/or possession.

You can access the full report here.


Leave a comment

CALIFORNIA BUREAU OF MEDICAL CANNABIS REGULATION – PROPOSED REGULATIONS FOR MEDICAL CANNABIS

BUREAU OF MEDICAL CANNABIS REGULATION RELEASES PROPOSED REGULATIONS FOR MEDICAL CANNABIS

The Bureau of Medical Cannabis Regulation (BMCR) today announced that its proposed licensing regulations for medical cannabis have been posted and the 45-day public comment period is now underway.

“The proposed licensing regulations for medical cannabis are the result of countless hours of research, stakeholder outreach, informational sessions and pre-regulatory meetings all across the state,” BMCR Chief Lori Ajax said. “And while we have done quite a bit of work and heard from thousands of people, there is still so much more to do. In order to make our program successful we still need your feedback.”

Individuals interested in reviewing the medical regulations for licensing dispensaries, distribution and transporters can do so by visiting the new Cannabis Web Portal, www.cannabis.ca.gov. At this site you will also find cultivation regulations, as well as manufacturing regulations for medical cannabis.

Part of today’s announcement includes the news of four public hearings for the purpose of public comment on the proposed medical licensing regulations. The Bureau encourages all interested stakeholders to review the proposed regulations and come to a hearing near you to provide feedback. Hearing dates and locations are as follows:

June 1, 2017
10:00 a.m. – 1:00 p.m.
Adorni Center
1011 Waterfront Drive, Eureka, CA 95501

June 8, 2017
10:00 a.m. – 1:00 p.m.
Junipero Serra Building
320 W. Fourth Street, Los Angeles, CA 90013

June 9, 2017
10:00 a.m. – 1:00 p.m.
Department of Consumer Affairs, Hearing Room, S-102
1625 North Market Boulevard, Sacramento, CA  95834

June 13, 2017
1:00 p.m. – 4:00 p.m.
King Library, Second Floor
150 E. San Fernando Street, San Jose, CA 95112

Those who wish to provide feedback and are unable to attend one of the four listed sessions above, can get involved in the regulatory process by following the steps outlined here – http://www.bmcr.ca.gov/about_us/documents/17-065_public_comment.pdf.

There is currently budget trailer bill language designed to align the Medical Cannabis Safety and Regulation Act with Proposition 64, the Adult Use of Marijuana Act. If that bill passes, the bureau will withdraw these proposed regulations and propose a new set of regulations consistent with changes in the law.

However, public comments on the regulations published today are still very important.

“Many of the provisions in the licensing regulations published today will carry over to new regulations if the trailer bill passes,” said Chief Ajax. “Public comment now will provide valuable information and guide our efforts when crafting any new regulations.”

Beginning a little more than a year ago, the Bureau kicked off its outreach efforts with nine informational sessions in locations all around the state. Those sessions were followed up last Fall by eight pre-regulatory stakeholder meetings with discussions centering around issues related to general licensing requirements, and specific concepts related to the regulation of medical cannabis dispensaries, distributors and transporters. The feedback from those sessions can be reviewed here – http://www.bmcr.ca.gov/meetings/summaries.shtml.

For additional information about BMCR, or to subscribe to email alerts to hear about updates as they become available, please visit our website – http://www.bmcr.ca.gov/.

In addition, you can now follow the Bureau on social media!

Facebook: https://www.facebook.com/BMCRinfo/
Twitter: https://twitter.com/BmcrInfo


Leave a comment

Legalize It, a Zurich-based group, has launched a campaign to legally regulate cannabis across Switzerland

Could Switzerland Become the First European Country to Legally Regulate Cannabis?

Nine years after a Swiss referendum failed to gain public approval for cannabis legalisation, a campaign group has reignited the movement for reform.

Legalize It, a Zurich-based group, has launched a campaign to legally regulate cannabis across Switzerland. The objectives of the initiative, Legalize It describes, are three-fold: to allow adults the “freedom and right to consume cannabis”, to prevent those who seek cannabis from having to purchase from the “black market”, and to ensure increased investment into drug use prevention, related research, and social security. The funds for such investment, the group says, will be acquired from the taxation of cannabis sales, and savings on law enforcement expenditure.

The campaign comes in the form of a federal popular initiative, a legislative instrument by which Swiss citizens can suggest changes in the law. If the proposal garners 100,000 valid signatures from Swiss citizens, it will be put forward for debate by the Federal Council, the country’s highest executive authority, and the Federal Assembly, the highest legislative authority.

The Federal Palace of Switzerland. Source: Wikimedia Commons

The cultivation, sale, and use of cannabis are outlawed in Switzerland in almost all cases, however punishment for minor possession is relatively light. Under the current law, an adult found to be in possession of up to 10 grams of cannabis will be fined 100 Swiss francs (£78), and will not be criminally prosecuted. In 2015, there were a total of 18,366 such fines across Switzerland.

Around three percent of adult Swiss residents use cannabis monthly, and almost 40 per cent of adults claim to have used it at least once in their life, according to Addiction Monitoring in Switzerland.

An attempt to legally regulate cannabis was resoundingly opposed by the public in a 2008 referendum, in which 63 per cent of voters opposed the measure. However, the public’s view on the subject has changed over the past decade, according to Nino Forrer, spokesperson for Legalise It.

“Many other countries have legalised or decriminalised cannabis in some form since 2008 and the results are good […] Based on this new data, the Swiss people will see more benefits than harms in legalising cannabis, I’m sure”, Forrer told TalkingDrugs.

“There has not been a massive rise in cannabis consumption among the youth [in places that have legalised cannabis], no surge in traffic accidents, no massive increased health costs. Instead, many jurisdictions have put the extra money from cannabis taxes into public healthcare, infrastructure, and schools in order to improve the standard of living for their people.”

A legal cannabis crow in Colorado. Source: Brett Levin

For example, in 2016, the US state of Colorado collected over $150 million in cannabis sale taxes, of which around $50 million was directed to school projects. Similarly, Legalize Itclaims that taxing the drug could raise 100 million Swiss francs (£78 million) each year, based on their estimates of consumption rates.

Forrer believes that the success of foreign initiatives, such as that in Colorado, may be enough for the Swiss authorities and public to support Legalize It’s new campaign – but only if the message can be effectively be delivered.

“We have had very good responses so far! Many people in Switzerland were waiting for this initiative, so they are very happy that we have started it”, Forrer told us.

“Now, we will try to inform the public as much as possible in order to gather a strong activist base all over the country. Mass media affects our perception of cannabis to a large extent, so good press is needed in order to win over the minds of Swiss people”.

If this initiative proves successful, Switzerland could become the first country in Europe to introduce a legally regulated cannabis market.

Avinash Tharoor is the Editor of TalkingDrugs. He tweets at @AvinashTharoor


Leave a comment

20,000 German pharmacies; supply 3.6 million people daily and provide 150,000 jobs.

http://www.abda.de/newsletter-root/pressemitteilungen/abda-dav-vorsitzender-becker-erste-verbesserungen-fuer-patienten-ernste-herausforderungen-fuer-apotheken/

The laws recently decided to strengthen the medicines and technical aids can improve the care of many patients, but the pharmacies as providers currently facing serious challenges in the regulatory framework. The prohibition on mail for prescription drugs and the strengthening of drug price regulation associated one of the core concerns of pharmacists for the coming legislative term of the Bundestag. This conviction represents the chairman of the German Association of Pharmacists (DAV), Fritz Becker, in his Political Report to the opening of the 54th DAV Economic Forum in Berlin. In the pharmaceutical supply Support Act (AM-VSG) and (HHVG) in medicines and medical aids Supply Act partial success, although had been made, so Becker, but the good supply of medicines in itself is now at risk.

“That finally got the compensation will be adjusted for recipes requiring documentation and drugs, represents a recognition of our pharmaceutical services represent,” says Becker. It also’m him that it no longer intended to give exclusive contracts of insurance in the cytostatic supply. “The free Pharmacies choice – even with cytostatic drugs – is not Bookseller, but practiced patient and consumer protection.” For vaccines he was DAV-Chairman welcomed that the aids tenders now “confident that the delivery problems will fall by the tendering ban.” must take into account quality criteria and additional payments would be monitored more closely. “My fear is that not much will change for the insured in practice. Therefore, we must continue to be vigilant. Just small pharmacies “In addition, excessive documentation requirements could” to waive the provision of aids move “.

Looking at the regulatory and economic uncertainties and imponderables for pharmacies in the outgoing and next legislature Becker calls his colleagues to take decisive action on: “The year of the federal election is ready hold significant challenges for us has to face our profession and will provide – ! with confidence, unity and dedication “The DAV-chairman continued:” Let us continue to fight together for an excellent network of 20,000 pharmacies, which supplies daily 3.6 million people, produces 250,000 messenger services and provides 150,000 jobs. ”

 

 


Leave a comment

German researchers seek 25,000 marijuana users for study

http://www.ibtimes.co.uk/pot-smokers-wanted-german-researchers-seek-25000-marijuana-users-study-1618629

German researchers are hoping to get government backing for a new study that would see the recruitment of 25,000 recreational marijuana smokers.

The Research Initiative on Cannabis Consumption are seeking government approval to analyse the cannabis users in order to understand the effects of the drug after several years of use.

Their application is aimed at conducting a “Scientific Study on Cannabis Sequences for Mentally Healthy Adult Consumers” they say.

Germany legalised marijuana for medicinal purposes earlier in 2017 with new powers given to doctors to prescribe the drug to seriously ill patients at their discretion.

This, researchers say, paves the way for a new study analysing the longer-term effects of the drug.

Cannabis for recreational use is still illegal, but that hasn’t stopped 2,000 people already signing up for the study, say the researchers.

The group announced plans to begin the study in November 2016 saying it wanted to analyse the mental effects on those addicted to the drug.

“In Germany several million people regularly get high on cannabis,” wrote lawyer and chief executive of the project Marko Dörre in a statement released after the plans were submitted.

“It is time that science becomes more engaged with recreational use.”

Marijuana
German researchers are hunting for 25,000 cannabis smokers for a new study.Reuters/John Vizcaino

As part of the study, those selected would be permitted to pick up 30 grams of pharmaceutical cannabis, usually reserved for medical patients, on a monthly basis.

Researchers are prohibiting anyone under 18, first-time marijuana smokers, as well as candidates with high-risk of addiction or psychiatric problems, from taking part in the study.

Before the new act on the Amendment of Narcotics Regulations passed earlier this year, only around 1,000 people with serious medical conditions were permitted to use cannabis.

“With the law implemented in March changing controlled substance regulations, the German parliament took on a new risk assessment of cannabis,” said Dörre.

“The new assessment will also benefit science.”

The BfArM declined to comment to Tagesspiegel as to whether it had in fact received the application or the chances of it being approved.